Physician profile
Brian A Perry
NPI 1295750388
$960.83
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $492 · 2021: $65.39.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $97.75 | 2020 | |
| Lilly USA, LLC | $90.75 | 2019-2020 | |
| Glaxosmithkline, LLC. | $89.22 | 2019-2020 | |
| Pfizer INC. | $87.73 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $78.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.79 | 2019-2020 | |
| Abbvie INC. | $66.90 | 2019-2021 | |
| Amgen INC. | $64.66 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.01 | 2019-2020 | |
| Genentech USA, INC. | $44.14 | 2019-2020 | |
| Allergan, INC. | $43.91 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.49 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $29.28 | 2019 | |
| Novo Nordisk INC | $25.71 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.86 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $14.67 | 2019 | |
| Amarin Pharma, INC. | $13.76 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.22 | 2019 | |
| Adlon Therapeutics L.P. | $11.44 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.19 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.